Skip to content

CastleKnight Management LP: MAT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CastleKnight Management LP on MAT, newest first. How the timeline and the estimate are built.

CastleKnight Management LP held 782,376 MAT shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 782,376 shares
    Change vs previous 13F +67,000 shares

    0.4% of the 13F portfolio, value $10,859,379.

    13F-HR 0000919574-26-005559 filed by CastleKnight Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 715,376 shares
    Change vs previous 13F +368,876 shares

    0.49% of the 13F portfolio, value $10,394,413.

    13F-HR 0000919574-26-003331 filed by CastleKnight Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 346,500 shares
    Change vs previous 13F -66,100 shares

    0.39% of the 13F portfolio, value $6,874,560.

    13F-HR 0000919574-26-001183 filed by CastleKnight Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 412,600 shares
    Change vs previous 13F +351,800 shares

    0.37% of the 13F portfolio, value $6,944,058.

    13F-HR 0000919574-25-006966 filed by CastleKnight Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 60,800 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $1,198,976.

    13F-HR 0000919574-25-004814 filed by CastleKnight Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).